Exthera Medical Corp. has closed a series B financing round, with part of the proceeds slated to go toward scale manufacturing of the company's therapeutic blood filter. The round was led by newcomer Fresenius Medical Care Ventures (FMCV) GmbH, with existing investors also participating.